OC&C advise Coalesce Capital on its investment in Examinetics

Monday 28 August 2023 | News

We’re thrilled to congratulate Coalesce Capital on backing its first deal with an investment in occupational-health compliance services company Examinetics. Coalesce is a private equity firm focused on investing in human capital-driven and technology-enabled business services companies.

Kansas-based Examinetics has over 50 years’ experience providing a range of testing and monitoring services that help organizations protect their workers as well as comply with health and safety regulations.

Their comprehensive suite of occupational health services delivers strategic value to more than 3,000 clients in over 18,000 locations annually.

This inaugural deal marks a significant chapter for Coalesce since its founding in 2022 by former Warburg Pincus executive Stephanie Geveda. We wish Coalesce and Examinetics every success following this transaction.

OC&C and Private Equity

We’re a leading strategy consultancy in the B2B sector, working with both major global corporations and local champions. We have advised investors on some of the largest transactions worldwide in recent years.

As a global strategy consulting firm, we work in close partnership with our clients to deliver outstanding results. In private equity, we have commercially advised on more than 500 successful transactions over the last 5 years, encompassing sell-side and buy-side roles.

How we can help:

  • We provide commercial due diligence and vendor due diligence for transactions and refinancing.
  • We assist investors with accelerating or improving their portfolio companies' performance.
  • We help investors identify potential investment themes or assets to target.

For more detail on our experience in this space, please contact:

Carl Evander, Partner 

We use cookies to give you the best possible experience on our website. By continuing to browse this site, you give consent for cookies to be used. For more details please read our Cookie policy.